Abaxis manufactures point-of-care blood analyzers which provide clinicians with rapid blood-constituent measurements for both humans and animals. The analyzers are designed to be portable, require minimal training, provide on-the-spot results, and offer built-in quality control and calibration. The analyzers come with the reagent discs required to perform several of the most common blood tests.
Abaxis markets the system under the name Piccolo®in the human medical market and under the name VetScan®in the veterinary market. The Abaxis Piccolo and VetScan systems have set a new standard in point-of-care diagnostics. These simple, portable, easy-to-use chemistry panel systems are marketed to decentralized clinical environments where sample logistics, patient transportation, and result-reporting problems have a significant impact on the quality of patient care.
By targeting such facilities and practices, Abaxis' product strategy is to provide clinicians and veterinarians with diagnostic tools to evaluate general health, organ function and disease status and to monitor therapies. Abaxis product development is driven by the requirements of the marketplace. Test methods and panels are first developed to gain entry into new markets. Follow-on test panels are later offered to address other specific needs in each target market.
A Brief History
The genesis of the Abaxis technology took place at the Oak Ridge National Laboratory, where, under contract to the National Aeronautics and Space Administration (NASA), scientists sought to develop and manufacture a small biochemical analyzer for use in space laboratories.
Abaxis was founded in April, 1989 under exclusive license with Oak Ridge to advance this technology and develop the first testing system capable of performing multiple blood tests from a single whole blood specimen without requiring a skilled lab technician.
In 1992, Abaxis completed the concept design for the then-named "EPOC 2000" system. This was a key milestone affording Abaxis the opportunity to make its initial public offering.
The VetScan system was introduced in the US veterinary market in July 1994. The Company initially launched the system with the Diagnostic Profile, a nine-test reagent product. Since then, the Company has added new test methods and new reagent rotor products targeted to fulfill different veterinary diagnostic needs.
The Company introduced its Piccolo system to the human marketplace in November 1995 with two reagent discs, General Health Panel 8 and General Health Panel 11. In November 1996, the Company introduced the Liver Panel Plus disc, which was enabled by the 510(k) clearance of the GGT test received from the FDA in September 1996. Subsequently, the Company has released other reagent disc products to meet different physicians' needs.